Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProvexis Share News (PXS)

Share Price Information for Provexis (PXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.65
Bid: 0.60
Ask: 0.70
Change: 0.00 (0.00%)
Spread: 0.10 (16.667%)
Open: 0.65
High: 0.00
Low: 0.00
Prev. Close: 0.65
PXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Idox Surges On Dye & Durham Takeover Offer

Fri, 19th Feb 2021 11:23

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

----------

AIM - WINNERS

----------

Idox, up 17% at 72.00 pence, 12-month range 24.5p-79p. The management software provider says it received a possible cash offer from Toronto-based provider of cloud-based software Dye & Durham. Idox says the proposed price is 75 pence per Idox share. Idox currently has around 443.7 million shares in issue. Dye & Durham stresses that there "can be no certainty that an offer will be made".

----------

Focusrite, up 5.5% at 1,033.00p, 12-month range 335p-1,090p. The music and audio products group says demand has remained strong in the first half, leading to revenue expectations ahead of internal forecasts.

----------

Provexis, up 3.7% at 0.84p, 12-month range 0.36p-1.49p. The food technology company says it has raised GBP50,000 through the placing of 6.7 million shares at 0.75p each. Says it will use the total amount raised to support its international growth plans as it highlighted a new production run for its Fruitflow+ Omega-3 heart-health dietary supplement product is in the process of being commissioned.

----------

Fiske, up 1.6% at 66p, 12-month range 56p-70p. The stockbroker says its results for the half year show a marked improvement on the prior year. Revenue for the six months to the end of November 2020 grew by 11% year-on-year to GBP2.8 million. Fiske's commission revenue was up 5% on the prior year, while its investment management fees increased by 14%.

----------

Fevertree Drinks, up 0.9% at 2,398.00p, 12-month range, 888.4p-2,587p. UBS starts coverage on the tonic water maker at Buy. Fevertree is one of the biggest companies on AIM with a market value of GBP2.8 billion.

----------

AIM - LOSERS

----------

Horizonte Minerals, down 7.5% at 8.56p. The Brazil-focused nickel development firm says it raised around GBP18 million via the placing of 162.7 million shares at a price of 7.5p per placing share. The proceeds will be used to initiate specific early works and advance long-lead time items linked to the start of construction of the company's Araguaia ferro-nickel project in Brazil.

----------

Jangada Mines, down 6.3% at 9.60p, 12-month range 0.9p-12.44p. The natural resource company says it raised GBP1.3 million via a placing of 13.9 million shares at 9.0p each, which will allow it to continue development at its Brazilian vanadiam project.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
23 Sep 2015 15:06

AGM, EGM Calendar - Week Ahead

Read more
4 Sep 2015 07:37

Provexis Narrows Annual Loss As Fruitflow Product Grows Strong Sales

Read more
3 Jul 2015 07:00

Provexis Raises GBP280,000 Via PrimaryBid.com Platform (ALLISS)

Read more
29 Jun 2015 07:14

Provexis Sees Encouraging Results From Oslo University Collaboration

Read more
4 Jun 2015 06:51

Provexis Agrees Better Terms On Fruitflow Deal; Loss To Narrow

Read more
6 Feb 2015 14:49

Sector movers: Food stocks binned after Tate & Lyle profit warning

Tate & Lyle was dampening the food sector in London on Friday after the sweeteners maker disappointed investors with its second profit warning in just four months. Tate & Lyle said it now expects adjusted pre-tax profits for the year ending 31 March to be below previous guidance of £230m-245m. The

Read more
30 Dec 2014 10:10

Provexis halves interim losses thanks to reduced Fruitflow costs

Provexis, developer of anti-thrombotic product Fruitflow, decreased its losses during the first half of the year due to a reduction in production costs. The AIM-listed company made first revenues during the period ended 30 September rose to £0.83m and losses before tax were more than halved from £0.

Read more
22 Sep 2014 07:25

UK MORNING BRIEFING: Tesco Leads London Declines After Another Shock

Read more
22 Sep 2014 05:20

UK AGM, EGM Calendar - Week Ahead

Read more
19 Sep 2014 15:09

UK AGM, EGM Calendar - Week Ahead

Read more
19 Sep 2014 05:25

UK AGM, EGM Calendar - Week Ahead

Read more
18 Sep 2014 15:23

UK AGM, EGM Calendar - Week Ahead

Read more
18 Sep 2014 05:23

UK AGM, EGM Calendar - Week Ahead

Read more
17 Sep 2014 15:01

UK AGM, EGM Calendar - Week Ahead

Read more
17 Sep 2014 05:19

UK AGM, EGM Calendar - Week Ahead

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.